PCV75 MULTI-CENTER STUDY ON THE IMPACT OF CYTOCHROME P450 3A4 AND P-GLYCOPROTEIN INTERACTING MEDICATIONS ON BLEEDING AND THROMBOEMBOLISM RISK IN NONVALVULAR ATRIAL FIBRILLATION PATIENTS MANAGED ON RIVAROXABAN THERAPY
May 1, 2019, 00:00
10.1016/j.jval.2019.04.511
https://www.valueinhealthjournal.com/article/S1098-3015(19)30703-X/fulltext
Title :
PCV75 MULTI-CENTER STUDY ON THE IMPACT OF CYTOCHROME P450 3A4 AND P-GLYCOPROTEIN INTERACTING MEDICATIONS ON BLEEDING AND THROMBOEMBOLISM RISK IN NONVALVULAR ATRIAL FIBRILLATION PATIENTS MANAGED ON RIVAROXABAN THERAPY
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)30703-X&doi=10.1016/j.jval.2019.04.511
First page :
Section Title :
Open access? :
No
Section Order :
10146